WebJun 15, 2024 · Elgia Therapeutics, a biotechnology company that aims to eliminate low-grade inflammation, today announced seed funding that will accelerate the development of novel treatments for chronic inflammatory and fibrotic diseases. The funding was led by Viva BioInnovator, the specialized investment and incubation arm of Shanghai-based Viva … WebMar 11, 2024 · Stacie Canan is the Chief Operating Officer at Elgia Therapeutics based in La Jolla, California. Previously, Stacie was the Executive Director at Bristol-Myers Squibb and also held positions at Pfizer, Agouron Pharmaceuticals, Ligand Pharmaceuticals. Stacie received a Bachelor of Science degree from Penn State University and a Predoctoral ...
Similar companies to Elgia Therapeutics VentureRadar
WebThe Elgia team has discovered how metabolic stress drives inflammation and fibrosis and has identified untapped protein targets for small molecule drug discovery. By combining these pioneering biological insights with R&D expertise, Elgia is creating innovative … Contact General Inquiries Elgia Therapeutics … Who We Are Overview Elgia Therapeutics is a venture-backed biopharmaceutical … Pipeline Inflammation: Hallmark and Driver of Numerous Diseases The drug … The Elgia targets, caspase-1, caspase-2, caspase-6 and TBK1/IKKε, are … Elgia Therapeutics, co-founded by multiple renown UCSD and UCSF professors, … Publications Key Target and Disease Publications Insightful discoveries and … Investors “Elgia has world-leading scientists in the biology of innate immunity, … Careers Join the Elgia Drug Discovery Team Elgia Therapeutics, a venture … WebJun 4, 2024 · A.R. Renslo is consultant at Theras, Inc., and Elgia Therapeutics and reports stock ownership in Elgia Therapeutics and Tatara Therapeutics. No potential conflicts of interest were disclosed by the other authors. KRAS mutations cause a quarter of cancer mortality and most are undruggable. Several inhibitors of the MAPK pathway are FDA … productivity levers
Elgia Therapeutics - Novel Therapies For Metabolic Inflammation …
WebElgia Therapeutics, Inc. 2024 - Aug 2024 3 years Elgia Therapeutics is a newly established venture-backed biotech company pursuing novel … WebviDA Therapeutics Inc. Private Company. Founded 2008. Canada. viDA Therapeutics, Inc. (viDA) is a private, venture-backed biopharmaceutical company committed to the discovery, development and commercialization of novel and targeted therapeutics for the treatment of autoimmune and age-related chronic inflammatory diseases. WebElgia Therapeutics is a biotechnology company that specializes in novel approaches for the treatment of chronic inflammatory and fibrotic … productivity life